EUDA Health (EUDA) Stock Price, News & Analysis

Company Overview

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market. EUDA Health Holdings became a publicly traded company on the Nasdaq following a business combination with a special purpose acquisition company. Information about its current leadership and the full scope of its operating subsidiaries is limited.

Key Stats

• Today's Range: $17.10 to $18.17
• 50-Day Range: $10.61 to $20.35
• 52-Week Range: $5.26 to $86.00
• Volume: 30,721 shs
• Average Volume: 52,844 shs
• Market Capitalization: $52.95 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $55.00
• Consensus Rating: Hold

EUDA Health Stock Analysis - MarketRank™

EUDA Health scored higher than 38% of companies evaluated by MarketBeat, and ranked 142nd out of 185 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

EUDA Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside Potential

EUDA Health has a consensus price target of $55.00, representing about 210.7% upside from its current price of $17.70.

Amount of Analyst Coverage

EUDA Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.09% of the float of EUDA Health has been sold short.

Short Interest Ratio / Days to Cover

EUDA Health has a short interest ratio ("days to cover") of 0.35, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in EUDA Health has recently increased by 36.30%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

EUDA Health does not currently pay a dividend.

Dividend Growth

EUDA Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

EUDA Health has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Real Estate companies.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, EUDA Health insiders have not sold or bought any company stock.

Percentage Held by Institutions

4.35% of the stock of EUDA Health is held by institutions.

Company Calendar

• Last Earnings: 5/05/2026
• Today: 9/18/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Real Estate
• Industry: Real Estate Management & Development
• Sub-Industry: Real Estate Services
• Current Symbol: NASDAQ:EUDA
• Previous Symbol: NASDAQ:LAX
• CIK: 1847846
• Web: www.eudahealth.com
• Phone: 65-6788-0388
• Fax: 65-6788-0068
• Employees: 2
• Year Founded: 2022

Price Target and Rating

• Average Price Target for EUDA Health: $55.00
• High Price Target: $55.00
• Low Price Target: $55.00
• Potential Upside/Downside: +211.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.18
• Quick Ratio: 0.18

Sales & Book Value

• Annual Sales: $6.82 million
• Price / Sales: 7.76
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.26) per share
• Price / Book: -7.83

Miscellaneous

• Outstanding Shares: 2,994,000
• Free Float: N/A
• Market Cap: $52.95 million
• Optionable: Not Optionable
• Beta: 0.59